All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B, Chronic-21503942

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	21503942	A55T	PreS	S	Hepatitis B, Chronic	G R C L	View
2	21503942	G145S	PreS	S	Hepatitis B, Chronic	G R C L	View
3	21503942	L30S	PreS	S	Hepatitis B, Chronic	G R C L	View
4	21503942	L97P	S	S	Hepatitis B, Chronic	G R C L	View
5	21503942	N207H	S	S	Hepatitis B, Chronic	G R C L	View
6	21503942	A5T	S	S	Hepatitis B, Chronic	G R C L	View
7	21503942	E54D	PreS	S	Hepatitis B, Chronic	G R C L	View
8	21503942	H71Q	PreS	S	Hepatitis B, Chronic	G R C L	View
9	21503942	I68T	PreS	S	Hepatitis B, Chronic	G R C L	View
10	21503942	I84L	PreS	S	Hepatitis B, Chronic	G R C L	View
11	21503942	R73H	S	S	Hepatitis B, Chronic	G R C L	View
12	21503942	W74X	S	S	Hepatitis B, Chronic	G R C L	View
13	21503942	P69L	PreS	S	Hepatitis B, Chronic	G R C L	View
14	21503942	P120A	S	S	Hepatitis B, Chronic	G R C L	View
15	21503942	T125A	S	S	Hepatitis B, Chronic	G R C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.